A different application of the same substance can yield amazing results. Silibinin, an extract of the milk thistle plant, has long been used as a supplemental treatment for liver disease. Research at the University of Colorado, however, is showing that silibinin can be used for so much more—in particular, to treat tumors, both cancerous and otherwise.
Spanish scientists are using the poison in wasp venom to develop a new weapon in the battle against breast cancer. Other researchers are exploring ways to incorporate wasp venom in a new class of anticancer drugs designed to attack different parts of cancer cells at the same time.
Oxitec, a British biotech company, is combatting the spread of Zika virus, dengue fever, yellow fever and chikungunya, by reducing the mosquito population through genetic engineering. Or rather, letting the bugs limit themselves. Fewer mosquitos? Fewer diseases spread.
More than 12 million people in the U.S. stop breathing periodically at night due to a serious sleep disorder called Obstructive Sleep Apnea. Even more concerning, the American Academy of Sleep Medicine estimates that 80 to 90 percent of adults with OSA are currently undiagnosed. Rutgers-based scientist Dr. Judith Neubauer and her team are working tirelessly to solve the mysteries of OSA and develop a treatment for this potentially life-threatening condition.
Dr. Irene Pepperberg, a chemist and “bird-scientist” at Harvard University, spends her time teaching African Grey parrots how to talk and is applying the same concepts in teaching autistic patients. Could these “bird-brained” parrots crack the code to understanding and re-wiring autism?
Hutchinson-Gilford Progeria Syndrome, or HGPS, affects 1 in every 20 million people worldwide and causes premature aging as well as early death. On a mission to defeat this devastating disease, Dr. Karima Djabli may have just found a solution to treating HGPS and understanding the aging process- something sitting right on our own dinner tables.